简
繁
EN
简
繁
EN
Home
Latest
Finance
IPO
ETF
Technology
Overseas
Research
HOME
·
159671.SZ
ICBCCS CSI Rare Metals Theme ETF(159671) falls 1.98%, with a share increase of 402 million units over the past six months
Tags:
ETF
159671.SZ
ICBCCS CSI Rare Metals Theme ETF
2026-07-09
ICBCCS CSI Rare Metals Theme ETF (159671) rises 5.31%, with a total net inflow of 99.8999 million yuan over the past 4 trading days
Tags:
ETF
159671.SZ
ICBCCS CSI Rare Metals Theme ETF
2026-06-22
ICBCCS CSI Rare Metals Theme ETF (159671) Rises 3.85%, Sees AUM Growth of 39.1679 Million Yuan Over the Past Two Weeks
Tags:
ETF
159671.SZ
ICBCCS CSI Rare Metals Theme ETF
2026-05-06
ICBCCS CSI Rare Metals Theme ETF(159671) Rises 0.51%, Poised for Four Consecutive Days of Gains
Tags:
ETF
159671.SZ
ICBCCS CSI Rare Metals Theme ETF
2026-04-21
Energy Storage Demand Becomes New Engine for Lithium Consumption,ICBCCS CSI Rare Metals Theme ETF(159671) Up Nearly 3%
Tags:
Rare Metal ETF Fund
ETF
159671.SZ
2026-01-09
ICBCCS CSI Rare Metals Theme ETF(159671) Falls Nearly 2%, Latest Scale Hits One-Month High
Tags:
Rare Metal ETF Fund
159671.SZ
ETF
2026-01-08
ICBCCS CSI Rare Metals Theme ETF(159671) Rises Nearly 2%, Aiming for Fifth Consecutive Gain
Tags:
Rare Metal ETF Fund
159671.SZ
ETF
2026-01-07
Featured News
Finance
Shenwan Hongyuan (06806.HK): Shenwan Hongyuan Securities Obtains Registration Approval for Perpetual Subordinated Bonds with a Ceiling of RMB 30 Billion
Finance
Luxxu Group(01327.HK): Executive Director Yang Xi Resigns; Liang Yanhuang Appointed as Authorised Representative
Finance
United Laboratories (03933.HK): New Specification of Sodium Hyaluronate Eye Drops Approved for Marketing
Finance
Dongjiang Environmental (00895.HK): 2026 Interim Performance Forecast, Expected Net Loss of RMB 250 Million to RMB 270 Million
Finance
CSPC Pharmaceutical Group (01093.HK): Albumin-Bound Docetaxel Combined with Anitumab Granted Breakthrough Therapy Designation
Finance
China Everbright Water (01857.HK): Completes Issuance of Phase 1 Medium-Term Notes of 2026 with Principal of RMB 1.5 Billion
Finance
MicroTech Medical(02235.HK): Continuous Glucose Monitoring System Secures Marketing Approval in South Korea
Finance
Overseas Chinese Town Asia (03366.HK): 100% Equity Interest in Huizhou Project Put Up for Public Listing Sale, Winning Bid Price at Approximately RMB 307 Million
Finance
Sino Biopharmaceutical (01177.HK): TRD205 (AT2R Antagonist) Included in CDE’s Breakthrough Therapy Designation List
Finance
Weigao Group(01066.HK): Controlling Shareholder Adds Approximately 15.5988 Million H Shares, Cumulative Share Purchase Hits Around 30.55 Million Shares
Scan QR Code
Download App